Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RRM1 encodes the large, catalytic subunit of ribonucleotide reductase (RR), an essential enzyme for DNA synthesis. This enzyme catalyzes the conversion of ribonucleotides to deoxyribonucleotides, providing the precursors required for DNA replication and repair. The activity of RR is crucial during the S phase of dividing cells when DNA synthesis occurs. Alterations or dysregulation in this gene or its chromosomal region have been linked with various cancers and Beckwith-Wiedemann syndrome.
Ribonucleotide reductase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribonucleotide reductase catalytic subunit M1 (RRM1).